Physician profile
Thomas B Mcelwee
NPI 1790761310
$1,055.03
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $35.76 · 2021: $131 · 2022: $416 · 2023: $83.65 · 2024: $22.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $124.34 | 2019 | |
| Davol INC. | $96.74 | 2019-2020 | |
| Incyte Corporation | $95.83 | 2021-2022 | |
| Abbvie INC. | $68.22 | 2022 | |
| Karyopharm Therapeutics INC. | $56.09 | 2022 | |
| Genzyme Corporation | $53.37 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $47.76 | 2022 | |
| Surmodics, INC. | $40.80 | 2023 | Sublime Radial Access Guide Sheath, Pounce Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Cook Medical LLC | $38.04 | 2019 | |
| Peerless Surgical INC. | $37.72 | 2021 | |
| Csl Behring | $36.57 | 2019 | |
| Medtronic, INC. | $35.65 | 2023-2024 | Pteye Parathyroid Detection System, Plasmablade(Tm) |
| Portola Pharmaceuticals, LLC | $31.15 | 2019 | |
| Medtronic Vascular, INC. | $27.51 | 2019 | |
| Eisai INC. | $26.78 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| G1 Therapeutics, INC. | $23.03 | 2022 | |
| Janssen Biotech, INC. | $20.45 | 2022 | |
| Tersera Therapeutics LLC | $19.90 | 2022 | |
| Allergan, INC. | $18.43 | 2019 | |
| Innocoll Pharmaceuticals Limited | $18.17 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.96 | 2019 | |
| Exelixis INC. | $16.55 | 2021 | |
| Mozarc Medical US LLC | $15.92 | 2023 | Argyle |
| Seagen INC. | $15.49 | 2022 | |
| Pharmacosmos Therapeutics INC. | $14.76 | 2022 | |
| Heron Therapeutics, INC. | $14.14 | 2022 | |
| Northgate Technologies, INC. | $13.50 | 2023 | Smoke Removel - Nebulae |
| Tetraphase Pharmaceuticals, INC. | $11.18 | 2019 | |
| Cardiovascular Systems INC. | $10.00 | 2022 | |
| Kerecis Limited | $8.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mcelwee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.